A

Aquestive Therapeutics
D

AQST

4.55500
USD
0.05
(1.00%)
مغلق
حجم التداول
34,450
الربح لكل سهم
-0
العائد الربحي
-
P/E
-10
حجم السوق
415,316,669
أصول ذات صلة
    B
    BHC
    -0.27000
    (-3.08%)
    8.48500 USD
    B
    BMRN
    -2.200
    (-3.35%)
    63.440 USD
    L
    LQDT
    -0.135
    (-0.54%)
    24.870 USD
    L
    LXRX
    -0.07740
    (-7.34%)
    0.97760 USD
    O
    OMER
    -0.19000
    (-2.73%)
    6.76000 USD
    R
    RUBY
    0
    (0%)
    0.000000 USD
    S
    SUPN
    -0.610
    (-1.69%)
    35.560 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    المزيد
الأخبار

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.